Pyromeconic acid-enriched Erigeron annuus water extract as a cosmetic ingredient for itch relief and anti-inflammatory activity

Minkyoung Kang,Minji Kang,Tae Hee Kim,Seong Un Jeong,Sangnam Oh
DOI: https://doi.org/10.1038/s41598-024-55365-2
IF: 4.6
2024-02-27
Scientific Reports
Abstract:Erigeron annuus (EA), traditionally used to treat disorders such as diabetes and enteritis, contains a variety of chemicals, including caffeic acid, flavonoids, and coumarins, providing antifungal and antioxidative benefits. However, the ingredients of each part of the EA vary widely, and there are few reports on the functionality of water extracts in skin inflammation and barrier protection. We assessed the therapeutic properties of the extract of EA without roots (EEA) and its primary ingredient, pyromeconic acid (PA), focusing on their antihistamine, anti-inflammatory, and antioxidative capabilities using HMC-1(human mast cells) and human keratinocytes (HaCaT cells). Our findings revealed that histamine secretion, which is closely related to itching, was notably reduced in HMC-1 cells following pretreatment with EEA (0.1% and 0.2%) and PA (corresponding concentration, 4.7 of 9.4 μg/mL). Similarly, they led to a marked decrease in the levels of pro-inflammatory cytokines, including IL-1β, IL-8, IL-6, and IFN-γ. Furthermore, EA and PA enhanced antioxidant enzymes, such as superoxide dismutase (SOD) and catalase (CAT), reduced malondialdehyde (MDA) production, and showed reactive oxygen species (ROS) scavenging activity in HaCaT cells. Moreover, at the molecular level, elevated levels of the pro-inflammatory cytokines IL-1β, IL-6, TARC, and MDC induced by TNF-α/IFN-γ in HaCaT cells were mitigated by treatment with EEA and PA. We also revealed the protective effects of EEA and PA against SDS-induced skin barrier dysfunction in HaCaT cells by enhancing the expression of barrier-related proteins. Using NanoString technology, a comprehensive analysis of gene expression changes indicated significant modulation of autoimmune and inflammatory genes by EEA and PA. In summary, this study suggests that EEA and the corresponding concentration of PA as an active ingredient have functional cosmetic applications to alleviate itching and improve skin health.
multidisciplinary sciences
What problem does this paper attempt to address?
The problem this paper attempts to address is the development of a plant-based therapeutic approach to effectively manage and alleviate skin health issues associated with skin inflammation and itching. Specifically, the study focuses on evaluating the efficacy of Erigeron annuus extract (EEA) and its major active component, pyrrolidone carboxylic acid (PA), in terms of antihistamine, anti-inflammatory, and antioxidant properties. The research utilized human mast cells (HMC-1) and human keratinocytes (HaCaT cells) to conduct experiments aimed at verifying the potential of these extracts in reducing oxidative stress, inhibiting inflammatory responses, and protecting skin barrier function. ### Main Issues: 1. **Management of Skin Inflammation and Itching**: - Skin inflammation and itching are common skin issues, frequently observed in diseases such as psoriasis, eczema, and atopic dermatitis. - Existing treatments (such as topical corticosteroids and antihistamines) are effective but have limited control over non-histaminergic itching and may cause side effects like skin atrophy and pigmentation with long-term use. 2. **Efficacy of Erigeron annuus Extract**: - Traditionally, Erigeron annuus has been used to treat various diseases such as diabetes and enteritis, containing rich chemical components including caffeic acid, flavonoids, and coumarins, which have antifungal and antioxidant effects. - However, the components vary significantly in different parts, and there is limited research on the function of aqueous extracts in skin inflammation and barrier protection. ### Research Objectives: - **Evaluate Antihistamine, Anti-inflammatory, and Antioxidant Capabilities**: Assess the capabilities of EEA and PA in antihistamine, anti-inflammatory, and antioxidant aspects through experiments with HMC-1 cells and HaCaT cells. - **Explore Molecular Mechanisms**: Use NanoString technology to analyze gene expression changes and investigate the effects of EEA and PA in regulating autoimmune and inflammatory genes. - **Verify Skin Barrier Protection**: Evaluate the protective effects of EEA and PA on skin barrier function through an SDS-induced skin barrier dysfunction model. ### Main Findings: - **Antioxidant Activity**: EEA and PA significantly increased cell viability under H2O2-induced oxidative stress, reduced ROS generation, and restored the activity of key antioxidant enzymes (such as SOD and CAT). - **Antihistamine and Anti-inflammatory Effects**: EEA and PA significantly inhibited the production of histamine and inflammatory cytokines (such as IL-1β, IL-6, IL-8, and IFN-γ) induced by PMACI. - **Skin Barrier Protection**: EEA and PA showed significant protective effects in the SDS-induced skin barrier dysfunction model, increasing the expression of skin barrier-related proteins (such as FLG and CASP14). - **Gene Expression Regulation**: NanoString technology analysis showed that EEA and PA significantly downregulated the expression of genes related to inflammation and autoimmunity, particularly genes in the interferon signaling pathway. ### Conclusion: This study demonstrates the significant effects of EEA and PA in anti-inflammatory, antihistamine, and antioxidant aspects, as well as their protective effects on the skin barrier, providing scientific evidence for the development of plant-based skin health products. This indicates that EEA and PA have potential application value in treating skin diseases associated with skin inflammation and itching.